IFP Advisors Inc Increases Holdings in Sensus Healthcare, Inc. (NASDAQ:SRTS)

IFP Advisors Inc grew its holdings in Sensus Healthcare, Inc. (NASDAQ:SRTS) by 37.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,800 shares of the company’s stock after acquiring an additional 5,100 shares during the period. IFP Advisors Inc owned about 0.11% of Sensus Healthcare worth $89,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also made changes to their positions in the company. Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Sensus Healthcare in the first quarter worth about $71,000. Millennium Management LLC lifted its position in shares of Sensus Healthcare by 256.6% in the fourth quarter. Millennium Management LLC now owns 85,329 shares of the company’s stock worth $590,000 after buying an additional 61,403 shares in the last quarter. Jane Street Group LLC lifted its position in shares of Sensus Healthcare by 233.7% in the fourth quarter. Jane Street Group LLC now owns 47,623 shares of the company’s stock worth $330,000 after buying an additional 33,353 shares in the last quarter. NewEdge Advisors LLC purchased a new stake in shares of Sensus Healthcare in the fourth quarter worth about $109,000. Finally, BNP Paribas Financial Markets purchased a new stake in shares of Sensus Healthcare in the fourth quarter worth about $47,000. 25.30% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

SRTS has been the topic of several analyst reports. Wall Street Zen cut Sensus Healthcare from a “hold” rating to a “sell” rating in a research note on Sunday, June 22nd. Maxim Group reduced their price objective on Sensus Healthcare from $14.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday, May 19th. Finally, HC Wainwright reissued a “buy” rating and set a $12.00 price objective on shares of Sensus Healthcare in a research note on Friday, April 4th.

Sensus Healthcare Price Performance

Shares of NASDAQ SRTS opened at $5.29 on Thursday. The business’s 50 day moving average is $4.78 and its two-hundred day moving average is $5.08. Sensus Healthcare, Inc. has a 1-year low of $4.01 and a 1-year high of $9.33. The stock has a market capitalization of $86.97 million, a P/E ratio of 52.90 and a beta of 1.29.

Sensus Healthcare (NASDAQ:SRTS) last released its earnings results on Thursday, May 15th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.20). The business had revenue of $8.34 million for the quarter, compared to the consensus estimate of $7.23 million. Sensus Healthcare had a net margin of 4.56% and a return on equity of 3.34%. As a group, equities research analysts anticipate that Sensus Healthcare, Inc. will post 0.32 earnings per share for the current fiscal year.

Sensus Healthcare Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.